HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

被引：0
|
作者：
T Van Gorp
I Cadron
E Despierre
A Daemen
K Leunen
F Amant
D Timmerman
B De Moor
I Vergote
机构：
[1] Universitaire Ziekenhuizen Leuven,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[2] Katholieke Universiteit Leuven,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[3] Herestraat 49,Department of Electrical Engineering
[4] MUMC+,undefined
[5] GROW – School for Oncology and Developmental Biology,undefined
[6] ESAT-SCD/SISTA,undefined
[7] Katholieke Universiteit Leuven,undefined
[8] Kasteelpark Arenberg 10,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
HE4; CA125; ovarian cancer; Risk of Ovarian Malignancy Algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 870
页数：7
相关论文
共 50 条
  • [31] Diagnostic performances of HE4, CA125, RMI and ROMA for the detection of ovarian cancer in presumed benign ovarian tumours
    Dochez, V
    Randet, M.
    Renaudeau, C.
    Dimet, J.
    Le Thuaut, A.
    Caillon, H.
    Vaucel, E.
    Ducarme, G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 : 77 - 77
  • [32] Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer
    Granato, Teresa
    Midulla, Cecilia
    Longo, Flavia
    Colaprisca, Barbara
    Frati, Luigi
    Anastasi, Emanuela
    TUMOR BIOLOGY, 2012, 33 (05) : 1335 - 1339
  • [33] DISEASE RELAPSE IN OVARIAN CANCER PATIENTS DETECTED BY HE4 AND CA125
    Steffensen, K.
    Waldstrom, M.
    Brandslund, I.
    Lund, B.
    Sorensen, S. M.
    Petzold, M.
    Jakobsen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 187 - 188
  • [34] A Survey on the Role of Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA), and Risk of Malignancy Index (RMI) in Pelvic Mass
    Karimi-Zarchi, Mojgan
    Behtash, Nadereh
    Mousavi, Azamsadat
    Maghami, Fazemeh Ghaem
    Gilani, Mitra Moddares
    Chiti, Zohreh
    Barouti, Esmat
    Sheikhpour, Elnaz
    Javaheri, Atiyeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (12)
  • [35] Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
    Andersen, M. Robyn
    Goff, Barbara A.
    Lowe, Kimberly A.
    Scholler, Nathalie
    Bergan, Lindsay
    Drescher, Charles W.
    Paley, Pamela
    Urban, Nicole
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 378 - 383
  • [36] HE4 combined with CA125: favorable screening tool for ovarian cancer
    Nasrin Ghasemi
    Samira Ghobadzadeh
    Mahnaz Zahraei
    Hemn Mohammadpour
    Salahadin Bahrami
    Mohammad Bakhshi ganje
    Shokoh Rajabi
    Medical Oncology, 2014, 31
  • [37] Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis
    Zhang, Lei
    Chen, Ying
    Wang, Ke
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 135 - 144
  • [38] APPLICATION VALUE OF HE4, CA125 AND ROMA IN DIAGNOSIS OF THE OVARIAN CANCER
    Sun, Wenchao
    Wang, Jinfang
    Liu, Lubin
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1765 - 1769
  • [39] HE4 combined with CA125: favorable screening tool for ovarian cancer
    Ghasemi, Nasrin
    Ghobadzadeh, Samira
    Zahraei, Mahnaz
    Mohammadpour, Hemn
    Bahrami, Salahadin
    Ganje, Mohammad Bakhshi
    Rajabi, Shokoh
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [40] The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
    Han, Kyung Hee
    Park, Noh Hyun
    Kim, Jin Ju
    Kim, Sunmie
    Kim, Hee Seung
    Lee, Maria
    Song, Yong Sang
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)
12345